Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study.

Cancer Palliative care Qualitative research Quality of life Randomized controlled trial Symptom screening

Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
21 Jun 2023
Historique:
received: 21 01 2023
accepted: 07 06 2023
medline: 23 6 2023
pubmed: 21 6 2023
entrez: 21 6 2023
Statut: epublish

Résumé

Although early palliative care is recommended, resource limitations prevent its routine implementation. We report on the preliminary findings of a mixed methods study involving a randomized controlled trial (RCT) of Symptom screening with Targeted Early Palliative care (STEP) and qualitative interviews. Adults with advanced solid tumors and an oncologist-estimated prognosis of 6-36 months were randomized to STEP or symptom screening alone. STEP involved symptom screening at each outpatient oncology visit; moderate to severe scores triggered an email to a palliative care nurse, who offered referral to in-person outpatient palliative care. Patient-reported outcomes of quality of life (FACT-G7; primary outcome), depression (PHQ-9), symptom control (ESAS-r-CS), and satisfaction with care (FAMCARE P-16) were measured at baseline and 2, 4, and 6 months. Semi-structured interviews were conducted with a subset of participants. From Aug/2019 to Mar/2020 (trial halted due to COVID-19 pandemic), 69 participants were randomized to STEP (n = 33) or usual care (n = 36). At 6 months, 45% of STEP arm patients and 17% of screening alone participants had received palliative care (p = 0.009). Nonsignificant differences for all outcomes favored STEP: difference in change scores for FACT-G7 = 1.67 (95% CI: -1.43, 4.77); ESAS-r-CS = -5.51 (-14.29, 3.27); FAMCARE P-16 = 4.10 (-0.31, 8.51); PHQ-9 = -2.41 (-5.02, 0.20). Sixteen patients completed qualitative interviews, describing symptom screening as helpful to initiate communication; triggered referral as initially jarring but ultimately beneficial; and referral to palliative care as timely. Despite lack of power for this halted trial, preliminary results favored STEP and qualitative results demonstrated acceptability. Findings will inform an RCT of combined in-person and virtual STEP.

Identifiants

pubmed: 37341839
doi: 10.1007/s00520-023-07870-9
pii: 10.1007/s00520-023-07870-9
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

404

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM et al (2017) Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update. J Clin Oncol 35(1):96–112. https://doi.org/10.1200/JCO.2016.70.1474
doi: 10.1200/JCO.2016.70.1474 pubmed: 28034065
Jordan K, Aapro M, Kaasa S, Ripamonti CI, Scotte F, Strasser F et al (2018) European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol 29(1):36–43. https://doi.org/10.1093/annonc/mdx757
doi: 10.1093/annonc/mdx757 pubmed: 29253069
Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. The Lancet 383(9930):1721–1730. https://doi.org/10.1016/s0140-6736(13)62416-2
doi: 10.1016/s0140-6736(13)62416-2
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742. https://doi.org/10.1056/NEJMoa1000678
doi: 10.1056/NEJMoa1000678 pubmed: 20818875
Temel JS, Greer JA, El-Jawahri A, Pirl WF, Park ER, Jackson VA et al (2017) Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol 35(8):834–841. https://doi.org/10.1200/JCO.2016.70.5046
doi: 10.1200/JCO.2016.70.5046 pubmed: 28029308
Vanbutsele G, Pardon K, Van Belle S, Surmont V, De Laat M, Colman R et al (2018) Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial. Lancet Oncol 19(3):394–404. https://doi.org/10.1016/S1470-2045(18)30060-3
doi: 10.1016/S1470-2045(18)30060-3 pubmed: 29402701
Maltoni M, Scarpi E, Dall'Agata M, Zagonel V, Berte R, Ferrari D et al (2016) Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial. Eur J Cancer 65:61–68. https://doi.org/10.1016/j.ejca.2016.06.007
doi: 10.1016/j.ejca.2016.06.007 pubmed: 27472648
Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J et al (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the project ENABLE II randomized controlled trial. JAMA 302(7):741–749. https://doi.org/10.1001/jama.2009.1198
doi: 10.1001/jama.2009.1198 pubmed: 19690306 pmcid: 3657724
Lupu D (2010) American Academy of H, Palliative Medicine Workforce Task F. Estimate of current hospice and palliative medicine physician workforce shortage. J Pain Symptom Manage 40(6):899–911. https://doi.org/10.1016/j.jpainsymman.2010.07.004
doi: 10.1016/j.jpainsymman.2010.07.004 pubmed: 21145468
Sleeman KE, de Brito M, Etkind S, Nkhoma K, Guo P, Higginson IJ et al (2019) The escalating global burden of serious health-related suffering: projections to 2060 by world regions, age groups, and health conditions. Lancet Glob Health 7(7):e883–ee92. https://doi.org/10.1016/S2214-109X(19)30172-X
doi: 10.1016/S2214-109X(19)30172-X pubmed: 31129125 pmcid: 6560023
Hui D, Hannon BL, Zimmermann C, Bruera E (2018) Improving patient and caregiver outcomes in oncology: team-based, timely, and targeted palliative care. CA Cancer J Clin 68(5):356–376. https://doi.org/10.3322/caac.21490
doi: 10.3322/caac.21490 pubmed: 30277572 pmcid: 6179926
Vogt J, Beyer F, Sistermanns J, Kuon J, Kahl C, Alt-Epping B et al (2021) Symptom burden and palliative care needs of patients with incurable cancer at diagnosis and during the disease course. Oncologist 26(6):e1058–e1e65. https://doi.org/10.1002/onco.13751
doi: 10.1002/onco.13751 pubmed: 33687742 pmcid: 8176980
Rodin R, Swami N, Pope A, Hui D, Hannon B, Le LW et al (2022) Impact of early palliative care according to baseline symptom severity: secondary analysis of a cluster-randomized controlled trial in patients with advanced cancer. Cancer Med 11(8):1869–1878. https://doi.org/10.1002/cam4.4565
doi: 10.1002/cam4.4565 pubmed: 35142091 pmcid: 9041071
Zimmermann C, Pope A, Hannon B, Krzyzanowska MK, Rodin G, Li M et al (2021) Phase II Trial of Symptom screening with Targeted Early Palliative care for patients with advanced cancer. J Natl Compr Canc Netw 20(4):361–70.e3. https://doi.org/10.6004/jnccn.2020.7803
doi: 10.6004/jnccn.2020.7803 pubmed: 34492632
Creswell JW, Plano Clark VL (2018) Designing and conducting mixed methods research, 3rd edn. Sage Publications, Thousand Oaks, CA
Alcalde J, Hannon B, Zimmermann C (2023) Mixed Methods research. In: Higginson IJ, Costantini M, Preston NJ, Currow DC, Bruera E, Larkin PJ (eds) Research methods in palliative care, 2nd edn. Oxford University Press. In press
Farquhar MC, Ewing G, Booth S (2011) Using mixed methods to develop and evaluate complex interventions in palliative care research. Palliat Med 25(8):748–757. https://doi.org/10.1177/0269216311417919
doi: 10.1177/0269216311417919 pubmed: 21807749
Curry L, Nunez-Smith M (2015) Mixed methods in health sciences research: a practical primer. In:Thousand Oaks. SAGE Publications, Inc., California. https://doi.org/10.4135/9781483390659 https://methods.sagepub.com/book/mixed-methods-in-health-sciences-research-a-practical-primer
doi: 10.4135/9781483390659
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655
doi: 10.1097/00000421-198212000-00014 pubmed: 7165009
Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H (1983) Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 140(6):734–739. https://doi.org/10.1176/ajp.140.6.734
doi: 10.1176/ajp.140.6.734 pubmed: 6846631
Watanabe SM, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser F (2011) A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients. J Pain Symptom Manage 41(2):456–468. https://doi.org/10.1016/j.jpainsymman.2010.04.020
doi: 10.1016/j.jpainsymman.2010.04.020 pubmed: 20832987
Dudgeon D, King S, Howell D, Green E, Gilbert J, Hughes E et al (2012) Cancer Care Ontario's experience with implementation of routine physical and psychological symptom distress screening. Psychooncology 21(4):357–364. https://doi.org/10.1002/pon.1918
doi: 10.1002/pon.1918 pubmed: 21308858
Pereira J, Green E, Molloy S, Dudgeon D, Howell D, Krzyzanowska MK et al (2014) Population-based standardized symptom screening: Cancer Care Ontario's Edmonton Symptom Assessment System and performance status initiatives. J Oncol Pract 10(3):212–214. https://doi.org/10.1200/JOP.2014.001390
doi: 10.1200/JOP.2014.001390 pubmed: 24756143
Follwell M, Burman D, Le LW, Wakimoto K, Seccareccia D, Bryson J et al (2009) Phase II study of an outpatient palliative care intervention in patients with metastatic cancer. J Clin Oncol 27(2):206–213. https://doi.org/10.1200/JCO.2008.17.7568
doi: 10.1200/JCO.2008.17.7568 pubmed: 19064979
Ontario CC: managing symptoms, Side Effects & Well-Being. https://www.cancercareontario.ca/en/symptom-management . Accessed December 18 2022.
Mah K, Swami N, Le LW, Chow R, Hannon BL, Rodin G et al (2020) Validation of the 7-item Functional Assessment of Cancer Therapy-General (FACT-G7) as a short measure of quality of life in patients with advanced cancer. Cancer 126(16):3750–3757. https://doi.org/10.1002/cncr.32981
doi: 10.1002/cncr.32981 pubmed: 32459377
Hannon B, Dyck M, Pope A, Swami N, Banerjee S, Mak E et al (2015) Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer. J Pain Symptom Manage 49(5):945–952. https://doi.org/10.1016/j.jpainsymman.2014.10.013
doi: 10.1016/j.jpainsymman.2014.10.013 pubmed: 25523890
Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
doi: 10.1046/j.1525-1497.2001.016009606.x pubmed: 11556941 pmcid: 1495268
Zimmerman M (2012) Symptom severity and guideline-based treatment recommendations for depressed patients: implications of DSM-5's potential recommendation of the PHQ-9 as the measure of choice for depression severity. Psychother Psychosom 81(6):329–332. https://doi.org/10.1159/000342262
doi: 10.1159/000342262 pubmed: 22964496
Yanez B, Pearman T, Lis CG, Beaumont JL, Cella D (2013) The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research. Ann Oncol 24(4):1073–1078. https://doi.org/10.1093/annonc/mds539
doi: 10.1093/annonc/mds539 pubmed: 23136235
Lo C, Burman D, Rodin G, Zimmermann C (2009) Measuring patient satisfaction in oncology palliative care: psychometric properties of the FAMCARE-patient scale. Qual Life Res 18(6):747–752. https://doi.org/10.1007/s11136-009-9494-y
doi: 10.1007/s11136-009-9494-y pubmed: 19513815
Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR (2002) Clinical significance consensus meeting G. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77(4):371–383. https://doi.org/10.4065/77.4.371
doi: 10.4065/77.4.371 pubmed: 11936935
Ringash J, O'Sullivan B, Bezjak A, Redelmeier DA (2007) Interpreting clinically significant changes in patient-reported outcomes. Cancer 110(1):196–202. https://doi.org/10.1002/cncr.22799
doi: 10.1002/cncr.22799 pubmed: 17546575
Sandelowski M (2000) Whatever happened to qualitative description? Res Nurs Health 23(4):334–340. https://doi.org/10.1002/1098-240x(200008)23:4<334::aid-nur9>3.0.co;2-g
doi: 10.1002/1098-240x(200008)23:4<334::aid-nur9>3.0.co;2-g pubmed: 10940958
Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77–101. https://doi.org/10.1191/1478088706qp063oa
doi: 10.1191/1478088706qp063oa
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383. https://doi.org/10.1016/0021-9681(87)90171-8
doi: 10.1016/0021-9681(87)90171-8 pubmed: 3558716
Hannon B, Swami N, Pope A, Leighl N, Rodin G, Krzyzanowska M et al (2016) Early Palliative care and its role in oncology: a qualitative study. Oncologist 21(11):1387–1395. https://doi.org/10.1634/theoncologist.2016-0176
doi: 10.1634/theoncologist.2016-0176 pubmed: 27449522 pmcid: 5189624
Hannon B, Swami N, Rodin G, Pope A, Zimmermann C. Experiences of patients and caregivers with early palliative care: a qualitative study. Palliat Med 2016;31(1):72-81.   https://doi.org/10.1177/0269216316649126 .
Zimmermann C, Swami N, Krzyzanowska M, Leighl N, Rydall A, Rodin G et al (2016) Perceptions of palliative care among patients with advanced cancer and their caregivers. CMAJ 188(10):E217–Ee27. https://doi.org/10.1503/cmaj.151171
doi: 10.1503/cmaj.151171 pubmed: 27091801 pmcid: 4938707
Hannon B, Mak E, Al Awamer A, Banerjee S, Blake C, Kaya E et al (2021) Palliative care provision at a tertiary cancer center during a global pandemic. Support Care Cancer 29(5):2501–2507. https://doi.org/10.1007/s00520-020-05767-5
doi: 10.1007/s00520-020-05767-5 pubmed: 32929539
Tasneem S, Kim A, Bagheri A, Lebret J (2019) Telemedicine video visits for patients receiving palliative care: a qualitative study. Am J Hosp Palliat Care 36(9):789–794. https://doi.org/10.1177/1049909119846843
doi: 10.1177/1049909119846843 pubmed: 31064195
Eastman P, Dowd A, White J, Carter J, Ely M (2021) Telehealth: rapid adoption in community palliative care due to COVID-19: patient and professional evaluation. BMJ Support Palliat Care. https://doi.org/10.1136/bmjspcare-2021-002987

Auteurs

Camilla Zimmermann (C)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. camilla.zimmermann@uhn.ca.
Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. camilla.zimmermann@uhn.ca.
Division of Medical Oncology, Faculty of Medicine, University of Toronto, Toronto, Canada. camilla.zimmermann@uhn.ca.
Division of Palliative Medicine, Department of Medicine, University of Toronto, Toronto, Canada. camilla.zimmermann@uhn.ca.
Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Canada. camilla.zimmermann@uhn.ca.

Ashley Pope (A)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Breffni Hannon (B)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Division of Palliative Medicine, Department of Medicine, University of Toronto, Toronto, Canada.

Philippe L Bedard (PL)

Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Division of Medical Oncology, Faculty of Medicine, University of Toronto, Toronto, Canada.
Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Gary Rodin (G)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Canada.

Neesha Dhani (N)

Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Division of Medical Oncology, Faculty of Medicine, University of Toronto, Toronto, Canada.
Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Madeline Li (M)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Canada.

Leonie Herx (L)

Division of Palliative Medicine, Department of Medicine, Queen's University, Kingston, Canada.

Monika K Krzyzanowska (MK)

Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Division of Medical Oncology, Faculty of Medicine, University of Toronto, Toronto, Canada.
Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Doris Howell (D)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Faculty of Nursing, University of Toronto, Toronto, Canada.

Jennifer J Knox (JJ)

Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Division of Medical Oncology, Faculty of Medicine, University of Toronto, Toronto, Canada.
Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Natasha B Leighl (NB)

Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Division of Medical Oncology, Faculty of Medicine, University of Toronto, Toronto, Canada.
Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Srikala Sridhar (S)

Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Division of Medical Oncology, Faculty of Medicine, University of Toronto, Toronto, Canada.
Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Amit M Oza (AM)

Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Division of Medical Oncology, Faculty of Medicine, University of Toronto, Toronto, Canada.
Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Stephanie Lheureux (S)

Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Division of Medical Oncology, Faculty of Medicine, University of Toronto, Toronto, Canada.
Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Christopher M Booth (CM)

Division of Medical Oncology, Kingston Health Sciences Centre, Kingston, Canada.
Department of Oncology, Queen's University, Kingston, Canada.
Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.

Geoffrey Liu (G)

Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Division of Medical Oncology, Faculty of Medicine, University of Toronto, Toronto, Canada.
Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Jacqueline Alcalde Castro (JA)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Division of Palliative Medicine, Department of Medicine, University of Toronto, Toronto, Canada.

Nadia Swami (N)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Rachel Sue-A-Quan (R)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Anne Rydall (A)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Lisa W Le (LW)

Department of Biostatistics, University Health Network, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH